Author:
Boucher Helen W.,Patterson Thomas F.
Publisher
Springer International Publishing
Reference134 articles.
1. Thompson GR III, Patterson TF. Chapter 257. Aspergillus species. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, vol. 2. 9th ed. Philadelphia, PA: Elsevier; 2020. p. 3103–16.
2. Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1–e60.
3. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin b for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347:408–15.
4. Maertens JA, Raad II, Marr KA, et al. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (secure): a phase 3, randomised-controlled, non-inferiority trial. Lancet. 2016;387:760–9.
5. Maertens JA, Rahav G, Lee DG, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021;397:499–509.